Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04830592
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-23
First Post:
2021-03-31
Brief Title:
A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Akamis Bio
Organization:
Akamis Bio
Organization Data
Organization:
Akamis Bio
Class:
INDUSTRY
Study ID:
NG-641-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Akamis Bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None